The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging of the hypertrophied left ventricle Myocardial Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

ESC 365 is supported by

ESC 365 is supported by